Argus analyst Jasper Hellweg raised his price target on HCA Healthcare to $150 and kept his Buy rating, saying the company’s recent acquisition of Mission Heath in North Carolina strengthens its regional presence. The analyst also cites the managements expectations of healthcare services demand rising 2.0-2.5% annually on “population growth, strong economic conditions, higher medical utilization, and an increase in the number of patients with chronic conditions.” Hellweg raises his FY18 EPS view on HCA Healthcare to $9.24 from $8.74, adding that its valuation is “attractive” at 14.4-times expected FY18 earnings vs. 17.5-times peer group average.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.